Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cytokines and malignant lymphomas].

A C Feller1, H Merz

  • 1Pathologisches Institut, Universität Würzburg.

Verhandlungen Der Deutschen Gesellschaft Fur Pathologie
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Revised version of the 4th edition of the WHO classification of malignant lymphomas : What is new?]

Der Pathologe·2018
Same author

Chronic Lymphocytic Leukemia (B-CLL) and Immunocytoma (LP-IC): Clinical and Prognostic Relevance of this Distinction.

Leukemia & lymphoma·2016
Same author

Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus.

Leukemia·2015
Same author

Pediatric Nodular Lymphocyte-predominant Hodgkin Lymphoma: Treatment Recommendations of the GPOH-HD Study Group.

Klinische Padiatrie·2015
Same author

Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma.

Leukemia·2015
Same author

Accumulation of STIM1 is associated with the degenerative muscle fibre phenotype in ALS and other neurogenic atrophies.

Neuropathology and applied neurobiology·2014

Deregulation of cytokine expression, particularly Interleukin-7 (IL-7) and Interleukin-9 (IL-9), is implicated in malignant lymphomas. IL-9 transfection in mice induced tumors, suggesting autocrine pathways in tumorigenesis.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Context:

  • Cytokines are key regulators of immune responses.
  • Dysregulated cytokine expression is linked to various pathological processes, including cancer.
  • Malignant lymphomas exhibit complex and heterogeneous cytokine expression patterns.

Purpose:

  • To investigate the role of cytokine expression in malignant lymphomas.
  • To explore the potential involvement of autocrine or paracrine cytokine pathways in tumor progression.
  • To examine the specific expression patterns of IL-7 and IL-9 in different lymphoma subtypes.

Summary:

  • This study analyzed cytokine expression in malignant lymphomas, revealing significant deregulation in several cases.
  • Interleukin-7 (IL-7) and Interleukin-9 (IL-9) expression were identified as potential distinguishing features of Hodgkin's disease and large cell anaplastic lymphomas.

Related Experiment Videos

  • Transfection of IL-9 into mouse T cells resulted in autocrine signaling and subsequent tumorigenesis, with tumors exhibiting similarities to human lymphomas.

    • Impact:

    • Highlights the critical role of cytokine dysregulation in lymphoma development.
    • Suggests IL-7 and IL-9 as potential biomarkers for specific lymphoma types.
    • Provides experimental evidence for the involvement of autocrine IL-9 signaling in lymphomagenesis, offering insights into therapeutic strategies.